Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Reshape Lifesciences

Stocks That Hit 52-Week Lows On Tuesday

On Tuesday, 44 companies hit new 52-week lows.

Stocks That Hit 52-Week Lows On Tuesday

Stocks That Hit 52-Week Lows On Tuesday

On Tuesday, 37 stocks hit new 52-week lows.

Recap Of Wednesday's Biotech Catalysts - End Of the Day Summary

Recap Of Wednesday's Biotech Catalysts - End Of the Day Summary

Bristol Myers Squibb (NYSE:BMY) and 2seventy bio (NASDAQ:TSVT) announced positive topline results from KarMMa-3, a Phase 3 study evaluating Abecma (idecabtagene vicleucel) compared to standard combination regimens in adults with multiple myeloma that is relapsed and refractory. Bristol Myers shares traded in a range of $73.95 to $75.32 on a day volume…

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Stocks That Hit 52-Week Lows On Wednesday

Wednesday saw 83 companies set new 52-week lows.

Reshape Lifesciences Earnings Perspective: Return On Capital Employed

According to data from Benzinga Pro, during Q1, Reshape Lifesciences's (NASDAQ:RSLS) reported sales totaled $2.44 million. Despite a 76.83% increase in earnings, the company posted a loss of $8.21 million.

12 Health Care Stocks Moving In Tuesday's Intraday Session

Earnings Outlook For Reshape Lifesciences

Reshape Lifesciences (NASDAQ:RSLS) is set to give its latest quarterly earnings report on Monday, 2022-05-23. Here's what investors need to know before the announcement. Analysts estimate that Reshape Lifesciences will report an earnings per share (EPS) of $-0.17.

inkl

Read news from The Economist, FT, and more,
with one subscription

Stocks That Hit 52-Week Lows On Wednesday

Stocks That Hit 52-Week Lows On Wednesday

During Wednesday's trading, 435 companies set new 52-week lows.

Stocks That Hit 52-Week Lows On Thursday

Stocks That Hit 52-Week Lows On Thursday

During Thursday, 849 stocks hit new 52-week lows.

Earnings Preview For Reshape Lifesciences

Earnings Preview For Reshape Lifesciences

Reshape Lifesciences (NASDAQ:RSLS) is set to give its latest quarterly earnings report on Monday, 2022-03-28. Here's what investors need to know before the announcement. Analysts estimate that Reshape Lifesciences will report an earnings per share (EPS) of $-0.17.

Organisations

Food and Drug Administration

Bristol Myers Squibb

Cassava Sciences

Liberty Broadband

BridgeBio Pharma

Blackrock Muniholdings

PDS Biotechnology

Elanco Animal Health

Reshape Lifesciences

TRACON Pharmaceuticals

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Topics

inkl

Read news from The Economist, FT, and more,
with one subscription

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play